PTGS2 and neurodegenerative disease: The results suggested that ginsenoside (65) was able to reduce the PGE2 and NO production via suppressing the COX-2 and iNOS expression hence signifying its importance in treating those neurodegenerative diseases where excessive activity of PGE2, NO, and COX-2 plays significant role (Zhang et al., 2006).